北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第二临床医学院  > 期刊论文
学科主题: 临床医学
题名:
Individualized glycaemic targets and pharmacotherapy in type 2 diabetes
作者: Bailey, Clifford J.1; Aschner, Pablo2; Del Prato, Stefano3; LaSalle, James4; Ji, Linong5; Matthaei, Stephan6; Global Partnership Effective Diabe
关键词: Glycaemic targets ; HbA(1c) ; type 2 diabetes ; individualized therapy ; Global Partnership
刊名: DIABETES & VASCULAR DISEASE RESEARCH
发表日期: 2013-09-01
DOI: 10.1177/1479164113490765
卷: 10, 期:5, 页:397-409
收录类别: SCI
文章类型: Review
WOS标题词: Science & Technology
类目[WOS]: Endocrinology & Metabolism ; Peripheral Vascular Disease
研究领域[WOS]: Endocrinology & Metabolism ; Cardiovascular System & Cardiology
关键词[WOS]: BLOOD-GLUCOSE CONTROL ; CARDIOVASCULAR OUTCOMES ; SEVERE HYPOGLYCEMIA ; ORAL MEDICATIONS ; FOLLOW-UP ; MELLITUS ; MANAGEMENT ; RECOMMENDATIONS ; THERAPY ; RISK
英文摘要:

The Global Partnership for Effective Diabetes Management, established to provide practical guidance to improve patient outcomes in diabetes, has developed and modified recommendations to improve glycaemic control in type 2 diabetes. The Global Partnership advocates an individualized therapeutic approach and, as part of the process to customize therapy, has previously identified specific type 2 diabetes patient subgroups that require special consideration. This article builds on earlier publications, expanding the scope of practical guidance to include newly diagnosed individuals with complications and women with diabetes in pregnancy. Good glycaemic control remains the cornerstone of managing type 2 diabetes, and plays a vital role in preventing or delaying the onset and progression of diabetic complications. Individualizing therapeutic goals and treatments to meet glycaemic targets safely and without delay remains paramount, in addition to a wider programme of care to reduce cardiovascular risk factors and improve patient outcomes.

语种: 英语
项目资助者: Bristol-Myers Squibb ; AstraZeneca LP ; Novartis Pharma AG
WOS记录号: WOS:000323113600002
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/56809
Appears in Collections:北京大学第二临床医学院_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Diabet Zentrum Quakenbruck, Quakenbruck, Germany
2.Univ Pisa, Sch Med, I-56100 Pisa, Italy
3.Med Arts Res Collaborat, Excelsior Springs, MO USA
4.Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China
5.Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England
6.Javeriana Univ, Endocrinol Unit, Sch Med, Bogota, Colombia

Recommended Citation:
Bailey, Clifford J.,Aschner, Pablo,Del Prato, Stefano,et al. Individualized glycaemic targets and pharmacotherapy in type 2 diabetes[J]. DIABETES & VASCULAR DISEASE RESEARCH,2013,10(5):397-409.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Bailey, Clifford J.]'s Articles
[Aschner, Pablo]'s Articles
[Del Prato, Stefano]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Bailey, Clifford J.]‘s Articles
[Aschner, Pablo]‘s Articles
[Del Prato, Stefano]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace